Inspire Medical Systems under investigation for securities violations.
PorAinvest
martes, 12 de agosto de 2025, 9:29 am ET1 min de lectura
INSP--
On August 4, 2025, Inspire reported its Q2 earnings, lowering its full-year revenue guidance and disclosing delays in the rollout of its "Inspire V" system. The company revealed that treatment centers had postponed the adoption of the new system due to not being able to bill Medicare until July 1, 2025. This news led to a significant drop in shares, with Inspire's stock falling by almost 40.6% in intraday trading on August 5, 2025 [1].
The Schall Law Firm is encouraging shareholders who suffered losses to contact Brian Schall, Esq., at 310-301-3335 or via email at bschall@schallfirm.com to discuss their rights. The firm specializes in securities class action lawsuits and shareholder rights litigation and represents investors worldwide [2].
Separately, Levi & Korsinsky has also commenced an investigation into Inspire Medical Systems, Inc. for possible violations of federal securities laws. The firm notes that Inspire's stock price fell by $46.44 per share following the release of its Q2 earnings report and guidance revision [3].
These investigations come amidst growing scrutiny over Inspire's financial disclosures and the accuracy of its earnings guidance. Investors are advised to stay informed and consult with legal professionals for guidance on potential legal action.
References:
[1] https://www.marketscreener.com/news/insp-investors-have-opportunity-to-join-inspire-medical-systems-inc-fraud-investigation-with-the-s-ce7c51dadb89f52d
[2] https://www.prnewswire.com/news-releases/insp-investors-have-opportunity-to-join-inspire-medical-systems-inc-fraud-investigation-with-the-schall-law-firm-302527267.html
[3] https://www.tradingview.com/news/reuters.com,2025-08-11:newsml_NFCywmw9:0-lost-money-on-inspire-medical-systems-inc-insp-possible-fraud-contact-levi-korsinsky-today/
JFU--
• Bloomberg financial analyst investigating Inspire Medical Systems • Allegations of false/misleading statements and undisclosed information • Company lowered Q2 revenue guidance, delayed rollout of Inspire V system • Shares fell 40.6% in intraday trading on August 5, 2025 • Investor losses encouraged to contact Brian Schall of the Schall Law Firm • Schall Law Firm filing claims on behalf of investors under securities laws • Allegations focus on Inspire Medical Systems' Q2 earnings report and guidance revision
Los Angeles, CA – August 12, 2025 – The Schall Law Firm has announced that it is investigating claims on behalf of investors of Inspire Medical Systems, Inc. (NYSE: INSP) for potential violations of the securities laws. The investigation centers on whether the company issued false or misleading statements and/or failed to disclose pertinent information to investors.On August 4, 2025, Inspire reported its Q2 earnings, lowering its full-year revenue guidance and disclosing delays in the rollout of its "Inspire V" system. The company revealed that treatment centers had postponed the adoption of the new system due to not being able to bill Medicare until July 1, 2025. This news led to a significant drop in shares, with Inspire's stock falling by almost 40.6% in intraday trading on August 5, 2025 [1].
The Schall Law Firm is encouraging shareholders who suffered losses to contact Brian Schall, Esq., at 310-301-3335 or via email at bschall@schallfirm.com to discuss their rights. The firm specializes in securities class action lawsuits and shareholder rights litigation and represents investors worldwide [2].
Separately, Levi & Korsinsky has also commenced an investigation into Inspire Medical Systems, Inc. for possible violations of federal securities laws. The firm notes that Inspire's stock price fell by $46.44 per share following the release of its Q2 earnings report and guidance revision [3].
These investigations come amidst growing scrutiny over Inspire's financial disclosures and the accuracy of its earnings guidance. Investors are advised to stay informed and consult with legal professionals for guidance on potential legal action.
References:
[1] https://www.marketscreener.com/news/insp-investors-have-opportunity-to-join-inspire-medical-systems-inc-fraud-investigation-with-the-s-ce7c51dadb89f52d
[2] https://www.prnewswire.com/news-releases/insp-investors-have-opportunity-to-join-inspire-medical-systems-inc-fraud-investigation-with-the-schall-law-firm-302527267.html
[3] https://www.tradingview.com/news/reuters.com,2025-08-11:newsml_NFCywmw9:0-lost-money-on-inspire-medical-systems-inc-insp-possible-fraud-contact-levi-korsinsky-today/
Divulgación editorial y transparencia de la IA: Ainvest News utiliza tecnología avanzada de Modelos de Lenguaje Largo (LLM) para sintetizar y analizar datos de mercado en tiempo real. Para garantizar los más altos estándares de integridad, cada artículo se somete a un riguroso proceso de verificación con participación humana.
Mientras la IA asiste en el procesamiento de datos y la redacción inicial, un miembro editorial profesional de Ainvest revisa, verifica y aprueba de forma independiente todo el contenido para garantizar su precisión y cumplimiento con los estándares editoriales de Ainvest Fintech Inc. Esta supervisión humana está diseñada para mitigar las alucinaciones de la IA y garantizar el contexto financiero.
Advertencia sobre inversiones: Este contenido se proporciona únicamente con fines informativos y no constituye asesoramiento profesional de inversión, legal o financiero. Los mercados conllevan riesgos inherentes. Se recomienda a los usuarios que realicen una investigación independiente o consulten a un asesor financiero certificado antes de tomar cualquier decisión. Ainvest Fintech Inc. se exime de toda responsabilidad por las acciones tomadas con base en esta información. ¿Encontró un error? Reportar un problema
Comentarios
Aún no hay comentarios